75887-54-6
75887-54-6 结构式
基本信息
10-乙氧基十氢-3,6,9-三甲基-3,12-环氧-12H-吡喃并[4,3-j]-1,2-苯并二氧杂环庚烷
SM-227
Areether
Artemotil
Arteether
ARPRINOCID
aArteether
NSC 665971
Unii-xgl7gfb9yi
Alpha Beta Arteether
常见问题列表
蒿乙醚为青蒿素的衍生物，作用同青蒿素，用于各种类型疟疾，也可用于不能口服其他抗疟药的患者。
蒿乙醚可用于各种类型疟疾效果良好，疟原虫清除快，使用方便，也可用于不能口服其他抗疟药的患者。对疟原虫红内期有直接杀灭作用，对红前期及组织期无作用。
蒿乙醚的副作用包括：肌内注射部位疼痛，建议在两臀间更换注射部位。间歇性、非特异性的中枢神经紊乱，如头痛。胃肠系统功能紊乱，如腹部不适、呕吐。 大剂量长期使用青蒿素及其衍生物，可出现损害中枢神经系统和引起心电图变化两方面的毒理作用。对于中枢神经，损害部位特异，位于脑桥和髓质。
IC50: 1.61 nM ( Plasmodium falciparum malaria)
The antimalarial activity of Artemotil is test in vitro against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum parasites. The mean 50% inhibitory concentration ( IC 50 ) for Artemotil is 1.61 nM (range 1.57-1.92 nM). Artemotil is approximately 2.5-fold more potent than artemisinin.
Artemotil treatment (25 mg/kg; intravenous injection; daily; for 7 days; Sprague-Dawley male rats) shows anorectic toxicity and causes significant reductions in food consumption and body weight after day 2. AUC on day 7 is 5-fold higher than AUC on day 1. The elimination t 1/2 of Artemotil is also prolonged from 13.7 hours (day 1) to 31.2 hours (day 7).
| Animal Model: | Sprague-Dawley male rats (220-280 g) |
| Dosage: | 25 mg/kg; 1 mL/kg body weight |
| Administration: | Intravenous injection; daily; for 7 days |
| Result: | Anorectic toxicity was observed, and that caused significant reductions in food consumption and body weight after day 2. |